Business & Industry
Trump Order to Go Heavy on D2C Pharmaceutical Ads
US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025.
This push, which happens to...
Business & Industry
Is US Planning Executive Order on Chinese Pharma Companies?
It is worth noting that the pharmaceutical sector’s recent source of novel molecules may as well be coming under threat. Apparently, it is the White House which is reportedly preparing an executive order that is going to place restrictions...
News
The Realities of the Nursing Shortage in Rural America
Along with multiple public health crises, the United States is also facing a nursing shortage, especially in rural parts of America. This problem is also exacerbated by rising costs, turnover, and competition in recruiting healthcare professionals. The factors contributing...
Health & Wellness
Green List by FDA to Cut Illegal GLP-1 Active Ingredients
The U.S. Food and Drug Administration has gone on to create a green list import alert in order to stop unapproved as well as unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering into the United States.
Because of the...
BioPharma
Novartis-Argo $5.2 Licensing Deal for Heart Drugs
Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...
News
Top Books Every Aspiring Pharmacist Should Read
Foundations That Shape the Profession
Every pharmacist begins with a bedrock of knowledge built from textbooks that serve as steady companions through study and practice. Among the most enduring titles stands "Remington: The Science and Practice of Pharmacy". Its chapters...
BioPharma
LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration
LOTTE BIOLOGICS, on September 1, 2025, announced that it has gone on to enter into a late-stage commercial contract manufacturing collaboration along with one of the global biopharmaceutical companies from the US.
It is well to be noted that this...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















